Tumor necrosis factor inhibitors as therapeutic agents for recurrent spontaneous abortion (Review)

Toth B, Vomstein K, Togawa R, Böttcher B, Hudalla H, Strowitzki T, Daniel V and Kuon RJ: The impact of previous live births on peripheral and uterine natural killer cells in patients with recurrent miscarriage. Reprod Biol Endocrinol. 17:722019. View Article : Google Scholar

Ozkan ZS, Deveci D, Simsek M, Ilhan F, Risvanli A and Sapmaz E: What is the impact of SOCS3, IL-35 and IL17 in immune pathogenesis of recurrent pregnancy loss? J Matern Fetal Neonatal Med. 28:324–328. 2015. View Article : Google Scholar

Pei CZ, Kim YJ and Baek KH: Pathogenetic factors involved in recurrent pregnancy loss from multiple aspects. Obstet Gynecol Sci. 62:212–223. 2019. View Article : Google Scholar

Ou H and Yu Q: Efficacy of aspirin, prednisone, and multivitamin triple therapy in treating unexplained recurrent spontaneous abortion: A cohort study. Int J Gynaecol Obstet. 148:21–26. 2020. View Article : Google Scholar

Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R, Llurba E and Gris JM: Tumor Necrosis Factor-Alpha and pregnancy: Focus on biologics. An updated and comprehensive review. Clin Rev Allergy Immunol. 53:40–53. 2017. View Article : Google Scholar

Siwetz M, Blaschitz A, El-Heliebi A, Hiden U, Desoye G, Huppertz B and Gauster M: TNF-alpha alters the inflammatory secretion profile of human first trimester placenta. Lab Invest. 96:428–438. 2016. View Article : Google Scholar

Saito S, Nakashima A, Shima T and Ito M: Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am J Reprod Immunol. 63:601–610. 2010. View Article : Google Scholar

Jerzak M, Ohams M, Gorski A and Baranowski W: Etanercept immunotherapy in women with a history of recurrent reproductive failure. Ginekol Pol. 83:260–264. 2012.

Fu J, Li L, Qi L and Zhao L: A randomized controlled trial of etanercept in the treatment of refractory recurrent spontaneous abortion with innate immune disorders. Taiwan J Obstet Gynecol. 58:621–625. 2019. View Article : Google Scholar

Winger EE and Reed JL: Treatment with tumor necrosis factor inhibitors and intravenous immunoglobulin improves live birth rates in women with recurrent spontaneous abortion. Am J Reprod Immunol. 60:8–16. 2008. View Article : Google Scholar

Sills ES, Walsh DJ, Shkrobot LV, Palermo GD and Walsh AP: Clinical experience with intravenous immunoglobulin and tnf-a inhibitor therapies for recurrent pregnancy loss. Ulster Med J. 78:57–58. 2009.

Sills ES, Perloe M, Tucker MJ, Kaplan CR and Palermo GD: Successful ovulation induction, conception, and normal delivery after chronic therapy with etanercept: A recombinant fusion anti-cytokine treatment for rheumatoid arthritis. Am J Reprod Immunol. 46:366–368. 2001. View Article : Google Scholar

Renaud SJ, Cotechini T, Quirt JS, Macdonald-Goodfellow SK, Othman M and Graham CH: Spontaneous pregnancy loss mediated by abnormal maternal inflammation in rats is linked to deficient uteroplacental perfusion. J Immunol. 186:1799–1808. 2011. View Article : Google Scholar

Gelber SE, Brent E, Redecha P, Perino G, Tomlinson S, Davisson RL and Salmon JE: Prevention of defective placentation and pregnancy loss by blocking innate immune pathways in a syngeneic model of placental insufficiency. J Immunol. 195:1129–1138. 2015. View Article : Google Scholar

Toth B, Wurfel W, Bohlmann M, Zschocke J, Rudnik-Schöneborn S, Nawroth F, Schleußner E, Rogenhofer N, Wischmann T, von Wolff M, et al: Recurrent Miscarriage: Diagnostic and Therapeutic Procedures. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry Number 015/050). Geburtshilfe Frauenheilkd. 78:364–381. 2018. View Article : Google Scholar

Winger EE, Reed JL, Ashoush S, Ahuja S, El-Toukhy T and Taranissi M: Treatment with adalimumab (Humira) and intravenous immunoglobulin improves pregnancy rates in women undergoing IVF. Am J Reprod Immunol. 61:113–120. 2009. View Article : Google Scholar

Baines MG, Duclos AJ, Antecka E and Haddad EK: Decidual infiltration and activation of macrophages leads to early embryo loss. Am J Reprod Immunol. 37:471–477. 1997. View Article : Google Scholar

Garrido-Gimenez C and Alijotas-Reig J: Recurrent miscarriage: Causes, evaluation and management. Postgrad Med J. 91:151–162. 2015. View Article : Google Scholar

Boomsma CM, Kavelaars A, Eijkemans MJ, Lentjes EG, Fauser BC, Heijnen CJ and Macklon NS: Endometrial secretion analysis identifies a cytokine profile predictive of pregnancy in IVF. Hum Reprod. 24:1427–1435. 2009. View Article : Google Scholar

Guo Z, Xu Y, Zheng Q, Liu Y and Liu X: Analysis of chromosomes and the T helper 17 and regulatory T cell balance in patients with recurrent spontaneous abortion. Exp Ther Med. 19:3159–3166. 2020.

Quenby S and Farquharson R: Uterine natural killer cells, implantation failure and recurrent miscarriage. Reprod Biomed Online. 13:24–28. 2006. View Article : Google Scholar

Lash GE and Bulmer JN: Do uterine natural killer (uNK) cells contribute to female reproductive disorders? J Reprod Immunol. 88:156–164. 2011. View Article : Google Scholar

Tuckerman E, Laird SM, Prakash A and Li TC: Prognostic value of the measurement of uterine natural killer cells in the endometrium of women with recurrent miscarriage. Hum Reprod. 22:2208–2213. 2007. View Article : Google Scholar

Tuckerman E, Mariee N, Prakash A, Li TC and Laird S: Uterine natural killer cells in peri-implantation endometrium from women with repeated implantation failure after IVF. J Reprod Immunol. 87:60–66. 2010. View Article : Google Scholar

Shimada S, Kato EH, Morikawa M, Iwabuchi K, Nishida R, Kishi R, Onoé K, Minakami H and Yamada H: No difference in natural killer or natural killer T-cell population, but aberrant T-helper cell population in the endometrium of women with repeated miscarriage. Hum Reprod. 19:1018–1024. 2004. View Article : Google Scholar

Manaster I and Mandelboim O: The unique properties of human NK cells in the uterine mucosa. Placenta. 29 (Suppl A):S60–S66. 2008. View Article : Google Scholar

Manaster I, Mizrahi S, Goldman-Wohl D, Sela HY, Stern-Ginossar N, Lankry D, Gruda R, Hurwitz A, Bdolah Y, Haimov-Kochman R, et al: Endometrial NK cells are special immature cells that await pregnancy. J Immunol. 181:1869–1876. 2008. View Article : Google Scholar

Kopcow HD, Allan DS, Chen X, Rybalov B, Andzelm MM, Ge B and Strominger JL: Human decidual NK cells form immature activating synapses and are not cytotoxic. Proc Natl Acad Sci USA. 102:15563–15568. 2005. View Article : Google Scholar

Guimond MJ, Wang B and Croy BA: Engraftment of bone marrow from severe combined immunodeficient (SCID) mice reverses the reproductive deficits in natural killer cell-deficient tg epsilon 26 mice. J Exp Med. 187:217–223. 1998. View Article : Google Scholar

Rai R, Sacks G and Trew G: Natural killer cells and reproductive failure-theory, practice and prejudice. Hum Reprod. 20:1123–1126. 2005. View Article : Google Scholar

Quenby S, Vince G, Farquharson R and Aplin J: Recurrent miscarriage: A defect in nature's quality control? Hum Reprod. 17:1959–1963. 2002. View Article : Google Scholar

Nakagawa K, Kwak-Kim J, Ota K, Kuroda K, Hisano M, Sugiyama R and Yamaguchi K: Immunosuppression with tacrolimus improved reproductive outcome of women with repeated implantation failure and elevated peripheral blood TH1/TH2 cell ratios. Am J Reprod Immunol. 73:353–361. 2015. View Article : Google Scholar

Raghupathy R, Makhseed M, Azizieh F, Hassan N, Al-Azemi M and Al-Shamali E: Maternal Th1- and Th2-type reactivity to placental antigens in normal human pregnancy and unexplained recurrent spontaneous abortions. Cell Immunol. 196:122–130. 1999. View Article : Google Scholar

Darmochwal-Kolarz D, Rolinski J, Leszczynska-Goarzelak B and Oleszczuk J: The expressions of intracellular cytokines in the lymphocytes of preeclamptic patients. Am J Reprod Immunol. 48:381–386. 2002. View Article : Google Scholar

Kwak-Kim JYH, Gilman-Sachs A and Kim CE: T helper 1 and 2 immune responses in relationship to pregnancy, nonpregnancy, recurrent spontaneous abortions and infertility of repeated implantation failures. Chem Immunol Allergy. 88:64–79. 2005.

Kwak-Kim JY, Chung-Bang HS, Ng SC, Ntrivalas EI, Mangubat CP, Beaman KD, Beer AE and Gilman-Sachs A: Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF. Hum Reprod. 18:767–773. 2003. View Article : Google Scholar

Wang WJ, Hao CF, Qu QL, Wang X, Qiu LH and Lin QD: The deregulation of regulatory T cells on interleukin-17-producing T helper cells in patients with unexplained early recurrent miscarriage. Hum Reprod. 25:2591–2596. 2010. View Article : Google Scholar

Zelenika D, Adams E, Humm S, Lin CY, Waldmann H and Cobbold SP: The role of CD4+ T-cell subsets in determining transplantation rejection or tolerance. Immunol Rev. 182:164–179. 2001. View Article : Google Scholar

Zenclussen AC, Gerlof K, Zenclussen ML, Sollwedel A, Bertoja AZ, Ritter T, Kotsch K, Leber J and Volk HD: Abnormal T-cell reactivity against paternal antigens in spontaneous abortion: Adoptive transfer of pregnancy-induced CD4+CD25+ T regulatory cells prevents fetal rejection in a murine abortion model. Am J Pathol. 166:811–822. 2005. View Article : Google Scholar

Yan L, Zheng D and Xu RH: Critical role of tumor necrosis factor signaling in mesenchymal stem cell-based therapy for autoimmune and inflammatory diseases. Front Immunol. 9:16582018. View Article : Google Scholar

Gabay C, Cakir N, Moral F, Roux-Lombard P, Meyer O, Dayer JM, Vischer T, Yazici H and Guerne PA: Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity. J Rheumatol. 24:303–308. 1997.

Sharief MK and Hentges R: Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis. N Engl J Med. 325:467–472. 1991. View Article : Google Scholar

Belkhelfa M, Rafa H, Medjeber O, Arroul-Lammali A, Behairi N, Abada-Bendib M, Makrelouf M, Belarbi S, Masmoudi AN, Tazir M and Touil-Boukoffa C: IFN-ү and TNF-α are involved during Alzheimer disease progression and correlate with nitric oxide production: A study in Algerian patients. J Interferon Cytokine Res. 34:839–847. 2014. View Article : Google Scholar

Idriss HT and Naismith JH: TNF alpha and the TNF receptor superfamily: Structure-function relationship(s). Microsc Res Tech. 50:184–195. 2000. View Article : Google Scholar

Clark DA: Immunological factors in pregnancy wastage: Fact or fiction. Am J Reprod Immunol. 59:277–300. 2008. View Article : Google Scholar

Clark DA: Anti-TNFalpha therapy in immune-mediated subfertility: State of the art. J Reprod Immunol. 85:15–24. 2010. View Article : Google Scholar

Said EA, Dupuy FP, Trautmann L, Zhang Y, Shi Y, El-Far M, Hill BJ, Noto A, Ancuta P, Peretz Y, et al: Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection. Nat Med. 16:452–459. 2010. View Article : Google Scholar

Wedekind L and Belkacemi L: Altered cytokine network in gestational diabetes mellitus affects maternal insulin and placental-fetal development. J Diabetes Complications. 30:1393–1400. 2016. View Article : Google Scholar

Banerjee P, Jana SK, Pasricha P, Ghosh S, Chakravarty B and Chaudhury K: Proinflammatory cytokines induced altered expression of cyclooxygenase-2 gene results in unreceptive endometrium in women with idiopathic recurrent spontaneous miscarriage. Fertil Steril. 99:179–187 e2. 2013. View Article : Google Scholar

Tangri S and Raghupathy R: Expression of cytokines in placentas of mice undergoing immunologically mediated spontaneous fetal resorptions. Biol Reprod. 49:850–856. 1993. View Article : Google Scholar

Ito K, Karasawa M, Kawano T, Akasaka T, Koseki H, Akutsu Y, Kondo E, Sekiya S, Sekikawa K, Harada M, et al: Involvement of decidual Valpha14 NKT cells in abortion. Proc Natl Acad Sci USA. 97:740–744. 2000. View Article : Google Scholar

Alkhuriji AF, Alhimaidi AR, Babay ZA and Wary AS: The relationship between cytokine gene polymorphism and unexplained recurrent spontaneous abortion in Saudi females. Saudi Med J. 34:484–489. 2013.

Aboutorabi R, Behzadi E, Sadegh MJ, Fatehi SP, Semsarzadeh S, Zarrin Y, Kazemi M, Rafiee L and Mostafavi FS: The study of association between polymorphism of TNF-α gene's promoter region and recurrent pregnancy loss. J Reprod Infertil. 19:211–218. 2018.

Gerriets V, Bansal P, Goyal A and Khaddour K: Tumor Necrosis Factor Inhibitors. StatPearls [Internet]. StatPearls Publishing; Treasure Island, FL: 2021

Wang T and He C: TNF-α and IL-6: The link between immune and bone system. Curr Drug Targets. 21:213–227. 2020. View Article : Google Scholar

Zhang Y, Liu H, Tang W, Qiu Q and Peng J: Resveratrol prevents TNF-α-induced VCAM-1 and ICAM-1 upregulation in endothelial progenitor cells via reduction of NF-κB activation. J Int Med Res. 48:3000605209451312020.

Brunner C, Seiderer J, Schlamp A, Bidlingmaier M, Eigler A, Haimerl W, Lehr HA, Krieg AM, Hartmann G and Endres S: Enhanced dendritic cell maturation by TNF-alpha or cytidine-phosphate-guanosine DNA drives T cell activation in vitro and therapeutic anti-tumor immune responses in vivo. J Immunol. 165:6278–6286. 2000. View Article : Google Scholar

Psarras A, Antanaviciute A, Alase A, Carr I, Wittmann M, Emery P, Tsokos GC and Vital EM: TNF-α regulates human plasmacytoid dendritic cells by suppressing IFN-α production and enhancing T cell activation. J Immunol. 206:785–796. 2021. View Article : Google Scholar

Conrad C, Di Domizio J, Mylonas A, Belkhodja C, Demaria O, Navarini AA, Lapointe AK, French LE, Vernez M and Gilliet M: TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis. Nat Commun. 9:252018. View Article : Google Scholar

Falcon BJ, Cotechini T, Macdonald-Goodfellow SK, Othman M and Graham CH: Abnormal inflammation leads to maternal coagulopathies associated with placental haemostatic alterations in a rat model of foetal loss. Thromb Haemost. 107:438–447. 2012. View Article : Google Scholar

Dignass AU, Hartmann F, Sturm A and Stein J: Management of inflammatory bowel diseases during pregnancy. Dig Dis. 27:341–346. 2009. View Article : Google Scholar

Pelechas E and Drosos AA: Etanercept biosimilar SB-4. Expert Opin Biol Ther. 19:173–179. 2019. View Article : Google Scholar

Spencer-Green G: Etanercept (Enbrel): Update on therapeutic use. Ann Rheum Dis. 59 (Suppl 1):i46–i49. 2000. View Article : Google Scholar

Elliot MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Katasikis P, Brennan FM, Bijl H, Ghrayeb J and Woody JN: Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum. 58 (2 Suppl):S92–S101. 2008. View Article : Google Scholar

Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W, et al: Maintenance infliximab for Crohn's disease: The ACCENT I randomised trial. Lancet. 359:1541–1549. 2002. View Article : Google Scholar

Yoo DH, Prodanovic N, Jaworski J, Miranda P, Ramiterre E, Lanzon A, Baranauskaite A, Wiland P, Abud-Mendoza C, Oparanov B, et al: Efficacy and safety of CT-P13 (biosimilar infliximab) in patients with rheumatoid arthritis: Comparison between switching from reference infliximab to CT-P13 and continuing CT-P13 in the PLANETRA extension study. Ann Rheum Dis. 76:355–363. 2017. View Article : Google Scholar

Zheng MK, Shih DQ and Chen GC: Insights on the use of biosimilars in the treatment of inflammatory bowel disease. World J Gastroenterol. 23:1932–1943. 2017. View Article : Google Scholar

Deeks ED: GP2015: An etanercept biosimilar. BioDrugs. 31:555–558. 2017. View Article : Google Scholar

Fiorino G, Gilardi D, Correale C, Furfaro F, Roda G, Loy L, Argollo M, Allocca M, Peyrin-Biroulet L and Danese S: Biosimilars of adalimumab: The upcoming challenge in IBD. Expert Opin Biol Ther. 19:1023–1030. 2019. View Article : Google Scholar

Nelson AL, Dhimolea E and Reichert JM: Development trends for human monoclonal antibody therapeutics. Nat Rev Drug Discov. 9:767–774. 2010. View Article : Google Scholar

Deeks ED: Certolizumab pegol: A review in inflammatory autoimmune diseases. BioDrugs. 30:607–617. 2016. View Article : Google Scholar

Maxwell LJ, Zochling J, Boonen A, Singh JA, Veras MM, Tanjong Ghogomu E, Benkhalti Jandu M, Tugwell P and Wells GA: TNF-alpha inhibitors for ankylosing spondylitis. Cochrane Database Syst Rev CD005468. 2015. View Article : Google Scholar

Steeland S, Libert C and Vandenbroucke RE: A new venue of TNF targeting. Int J Mol Sci. 19:14422018. View Article : Google Scholar

U.S. National Library of Medicine (NIH), . A Trial With Humanized TNFα Monoclonal Antibody Injection by Single Dose and Dose Escalation in Healthy Subjects. ClinicalTrials.gov Identifier: NCT02460393. NIH; Bethesda, MD: 2015, https://clinicaltrials.gov/ct2/show/NCT02460393June 2–2015